Subscribe free!

Find out why we're the #1 free penny stock alert newsletter


Shares of Dendreon Corp. (DNDN) Soar in Wednesday’s Trading

| |

Shares of Dendreon Corp. (NASDAQ: DNDN), a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients, are soaring in today’s trading.

At last check, DNDN shares were trading 7.36% higher at $6.71, with volume up from daily average of 6.22 million to 9.49 million. Year-to-date DNDN shares are down 12.24%, underperforming the Nasdaq, which has gained 9.22% in the same period.

DNDN shares are gaining in today’s trading after Summer Street Research initiated coverage on the company with a Buy rating.

Posted by on Wednesday, June 13th, 2012. Filed under Internet, Stocks. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Leave a Reply